Evidence map›Paper›PMID 17928334›Full record

ArticleJournal of virology2008

Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells.

Derek D C Ireland, Stephen A Stohlman, David R Hinton, Roscoe Atkinson, Cornelia C Bergmann

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Innate immune evasion strategies of SARS-CoV-2.Nature reviews. Microbiology · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The molecular virology of coronaviruses.The Journal of biological chemistry · 2020
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Promoting remyelination through cell transplantation therapies in a model of viral-induced neurodegenerative disease.Developmental dynamics : an official publication of the American Association of Anatomists · 2019
    Review
  19. Review
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Derek D C IrelandThe Cleveland Clinic, 2500 Euclid Avenue, NC30, Cleveland, OH 44195, USA.
Stephen A Stohlman
David R Hinton
Roscoe Atkinson
Cornelia C Bergmann
Cleveland Clinic Lerner College of Medicine · USUniversity of Southern California · US

Funding

VIRUS ENTRY AS A DETERMINANT OF MOUSE HEPATITIS VIRUS NEUROTROPISMP01NS018146 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERGMANN, CORNELIA · 1985 to 2007
$10.4M
Immune Regulation of CNS Viral RecrudescenceR01AI047249 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERGMANN, CORNELIA · 2001 to 2010
$3.1M
Immune Regulation of Viral RecrudescenceR56AI047249 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI BERGMANN, CORNELIA · 2012 to 2012
$393k
NIAID NIH HHS AI47249NIAID NIH HHS R01 AI047249NIAID NIH HHS R56 AI047249NINDS NIH HHS NS18146NINDS NIH HHS P01 NS018146
6 · The paper itself

Abstract

Neurotropic coronavirus infection induces expression of both beta interferon (IFN-beta) RNA and protein in the infected rodent central nervous system (CNS). However, the relative contributions of type I IFN (IFN-I) to direct, cell-type-specific virus control or CD8 T-cell-mediated effectors in the CNS are unclear. IFN-I receptor-deficient (IFNAR(-/-)) mice infected with a sublethal and demyelinating neurotropic virus variant and those infected with a nonpathogenic neurotropic virus variant both succumbed to infection within 9 days. Compared to wild-type (wt) mice, replication was prominently increased in all glial cell types and spread to neurons, demonstrating expanded cell tropism. Furthermore, increased pathogenesis was associated with significantly enhanced accumulation of neutrophils, tumor necrosis factor alpha, interleukin-6, chemokine (C-C motif) ligand 2, and IFN-gamma within the CNS. The absence of IFN-I signaling did not impair induction or recruitment of virus-specific CD8 T cells, the primary adaptive mediators of virus clearance in wt mice. Despite similar IFN-gamma-mediated major histocompatibility complex class II upregulation on microglia in infected IFNAR(-/-) mice, class I expression was reduced compared to that on microglia in wt mice, suggesting a synergistic role of IFN-I and IFN-gamma in optimizing class I antigen presentation. These data demonstrate a critical direct antiviral role of IFN-I in controlling virus dissemination within the CNS, even in the presence of potent cellular immune responses. By limiting early viral replication and tropism, IFN-I controls the balance of viral replication and immune control in favor of CD8 T-cell-mediated protective functions.

Indexed as

AnimalsCD8-Positive T-LymphocytesCentral Nervous SystemCentral Nervous System DiseasesChemokine CCL2Coronavirus InfectionsHistocompatibility Antigens Class IInterferon-gammaInterferon Type IInterleukin-6MiceMice, Inbred C57BLMice, KnockoutNeurogliaNeuronsNeutrophilsCcl2 protein, mouseChemokine CCL2Histocompatibility Antigens Class IInterferon-gammaInterferon Type IInterleukin-6Receptor, Interferon alpha-betaTumor Necrosis Factor-alpha

Identifiers

PMID17928334
PMCPMC2224360
OpenAlexW2132728252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.